Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3694053015 | Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3694054014 | Chlorhexidine hydrochloride 2.5 mg/g and tolnaftate 10 mg/g cutaneous powder | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Is a | Product containing tolnaftate (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | Tolnaftate (substance) | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | Skin agent | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | Chlorhexidine hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Is a | Tolnaftate+chlorhexidine hydrochloride | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | Topical agent | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Is a | Product containing chlorhexidine and tolnaftate (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has active ingredient | Skin agent | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has manufactured dose form | Drug powder | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has manufactured dose form | Cutaneous powder | true | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Is a | Product containing chlorhexidine in topical dosage form | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Is a | Product containing tolnaftate in topical dosage form | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength numerator value | 2.5 | false | Inferred relationship | Some | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has basis of strength substance (attribute) | Tolnaftate (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | Tolnaftate (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | Chlorhexidine hydrochloride | false | Inferred relationship | Some | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has basis of strength substance (attribute) | Chlorhexidine hydrochloride | false | Inferred relationship | Some | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength numerator value | 10 | false | Inferred relationship | Some | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Is a | Product containing only chlorhexidine and tolnaftate in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Plays role | Antifungal therapeutic role (role) | false | Inferred relationship | Some | ||
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has basis of strength substance (attribute) | Tolnaftate (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | Tolnaftate (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has basis of strength substance (attribute) | Chlorhexidine hydrochloride | true | Inferred relationship | Some | 2 | |
| Product containing precisely chlorhexidine hydrochloride 2.5 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous powder (clinical drug) | Has precise active ingredient | Chlorhexidine hydrochloride | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR